Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
PL02 - Will Personalised Therapies Ever “Cure” Metastatic NSCLC?
- Type: Plenary Session
- Track: Medical Oncology
- Presentations: 5
- Moderators:D. Gandara
- Coordinates: 10/28/2013, 08:15 - 09:45, Plenary Hall, Ground Level
-
+
PL02.0 - Chair Intro
08:15 - 08:20 | Author(s): D. Gandara
- Abstract
No abstract available for this presentation
-
+
PL02.1 - Identifying Druggable Targets Through Whole Genome Sequencing: TCGA
08:20 - 08:40 | Author(s): M. Meyerson
- Abstract
No abstract available for this presentation
-
+
PL02.2 - Dark Matter: Defining Oncogenic Drivers in the Epigenome
08:40 - 09:00 | Author(s): C.M. Rudin
- Abstract
Loading... -
+
PL02.3 - Tumour Heterogeneity as an Obstacle to Cure
09:00 - 09:20 | Author(s): C. Swanton
- Abstract
Loading... -
+
PL02.4 - What is Cure and How Can We Achieve This With Targeted Therapies?
09:20 - 09:40 | Author(s): T. Mok
- Abstract
No abstract available for this presentation
-
+
O01 - Prognostic and Predictive Biomarkers I
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:T. Mitsudomi
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
-
+
O01.08 - DISCUSSANT
11:45 - 12:00 | Author(s): D. Gandara
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO13 - SCLC I
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 11
- Moderators:C.K. Liam
- Coordinates: 10/29/2013, 10:30 - 12:00, Bayside 201 - 203, Level 2
-
+
MO13.01 - Disease control rate at 8 weeks predicts subsequent survival in platinum-treated extensive stage small cell lung cancer (ES-SCLC): a patient level analysis of SWOG trials
10:30 - 10:35 | Author(s): P. Lara
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MS13 - Statistics of Personalised Medicine
- Type: Mini Symposia
- Track: Statistics
- Presentations: 5
- Moderators:M. Redman
- Coordinates: 10/29/2013, 14:00 - 15:30, Parkside 110 A+B, Level 1
-
+
MS13.4 - The Future of RCTs in the Molecular Era?
15:05 - 15:25 | Author(s): D. Gandara
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO18 - NSCLC - Targeted Therapies IV
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 13
- Moderators:L. Horn
- Coordinates: 10/29/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
-
+
MO18.08 - Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer (SCCA).
16:55 - 17:00 | Author(s): V. Papadimitrakopoulou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
O21 - SCLC II
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:M. Ahn
- Coordinates: 10/29/2013, 16:15 - 17:45, Parkside Ballroom B, Level 1
-
+
O21.07 - A new prognostic model for relapsed/refractory extensive stage small cell lung cancer (ES-SCLC) derived from prospective SWOG trials: implications for study design
17:20 - 17:30 | Author(s): P. Lara
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO20 - Preclinical Therapeutic Models II
- Type: Mini Oral Abstract Session
- Track: Biology
- Presentations: 10
- Moderators:P. Waring
- Coordinates: 10/30/2013, 10:30 - 12:00, Bayside Gallery B, Level 1
-
+
MO20.04 - Divergent activity of afatinib (AFAT) and cetuximab (CET) in patient-derived xenograft (PDX) models of acquired erlotinib resistance.
10:45 - 10:50 | Author(s): P. Mack
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
